| Company Name: |
amyjet |
| Tel: |
4006800868;027-59626688 18771149750 |
| Email: |
sales@amyjet.com |
| Company Name: |
ChemeGen |
| Tel: |
18818260767 |
| Email: |
2625930290@qq.com |
|
| | 20-HETE-D6 Basic information |
| Product Name: | 20-HETE-D6 | | Synonyms: | 20-HETE-D6;20-HYDROXY-5Z,8Z,11Z,14Z-EICOSATETRAENOIC-16,16,17,17,18,18-D6 ACID | | CAS: | 2548939-89-3 | | MF: | C20H32O3 | | MW: | 320.47 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File |  |
| | 20-HETE-D6 Chemical Properties |
| solubility | DMF: 10 mg/ml; DMSO: 10 mg/ml; Ethanol: 10 mg/ml; PBS (pH 7.2): 500 μg/ml | | form | Liquid | | color | Colorless to light yellow |
| | 20-HETE-D6 Usage And Synthesis |
| Description | 20-HETE-d6 contains six deuterium atoms at the 16, 16', 17, 17', 18 and 18' positions. It is intended for use as an internal standard for the quantification of 20-HETE by GC- or LC-MS. 20-HETE is a cytochrome P450 (CYP450) metabolite postulated to play an autacoid role in the renal and cerebral vasculature.1 In rat cerebral microvessels, 20-HETE is a vasoconstrictor that mediates pressure-induced autoregulatory vasoconstriction.2 20-HETE is excreted mainly as the glucuronide conjugate. The concentration of free 20-HETE (20-40 pg/ml in human urine) is about 10-fold lower than the corresponding concentration of the 20-glucuronide.3 | | Uses | 20-HETE-d6 is the deuterium labeled 20-HETE[1]. | | References | 1. McGiff, J.C., and Quilley, J. 20-HETE and the kidney: Resolution of old problems and new beginnings Am. J. Physiol. 277(3),R607-R623(1999).
2. Gebremedhin, D., Lange, A.R., Lowry, T.F., et al. Production of 20-HETE and its role in autoregulation of cerebral blood flow Circ. Res. 87(1),60-65(2000).
3. Prakash, C., Zhang, J.Y., Falck, J.R., et al. 20-Hydroxyeicosatetraenoic acid is excreted as a glucuronide conjugate in human urine Biochem. Biophys. Res. Commun. 185(2),728-733(1992). |
| | 20-HETE-D6 Preparation Products And Raw materials |
|